Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Novel p38α mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain.

Tong SE, Daniels SE, Black P, Chang S, Protter A, Desjardins PJ.

J Clin Pharmacol. 2012 May;52(5):717-28. doi: 10.1177/0091270011405496. Epub 2011 Jun 9.

PMID:
21659629
2.

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.

Genovese MC, Cohen SB, Wofsy D, Weinblatt ME, Firestein GS, Brahn E, Strand V, Baker DG, Tong SE.

J Rheumatol. 2011 May;38(5):846-54. doi: 10.3899/jrheum.100602. Epub 2011 Feb 1.

PMID:
21285160

Supplemental Content

Support Center